Semler Scientific (NASDAQ:SMLR) Shares Gap Up – Time to Buy?

Shares of Semler Scientific, Inc. (NASDAQ:SMLR) gapped up before the market opened on Friday . The stock had previously closed at $58.24, but opened at $62.00. Semler Scientific shares last traded at $64.75, with a volume of 86,980 shares traded.

Semler Scientific Trading Up 11.1 %

The company has a market capitalization of $599.58 million, a P/E ratio of 31.55 and a beta of 1.18. The business’s 50-day simple moving average is $59.12 and its 200 day simple moving average is $39.32.

Semler Scientific (NASDAQ:SMLR) last released its quarterly earnings results on Monday, November 4th. The company reported $0.72 EPS for the quarter, topping analysts’ consensus estimates of $0.37 by $0.35. The company had revenue of $13.51 million for the quarter. Semler Scientific had a net margin of 27.00% and a return on equity of 20.31%.

Institutional Trading of Semler Scientific

A number of hedge funds have recently bought and sold shares of the stock. State Street Corp lifted its holdings in shares of Semler Scientific by 0.6% during the 3rd quarter. State Street Corp now owns 118,223 shares of the company’s stock worth $2,784,000 after acquiring an additional 725 shares during the period. Quest Partners LLC lifted its holdings in shares of Semler Scientific by 48.0% during the 3rd quarter. Quest Partners LLC now owns 2,520 shares of the company’s stock worth $59,000 after acquiring an additional 817 shares during the period. Newbridge Financial Services Group Inc. bought a new position in shares of Semler Scientific during the 2nd quarter worth about $34,000. US Bancorp DE lifted its holdings in shares of Semler Scientific by 60.8% during the 3rd quarter. US Bancorp DE now owns 3,064 shares of the company’s stock worth $72,000 after acquiring an additional 1,158 shares during the period. Finally, Rhumbline Advisers lifted its holdings in shares of Semler Scientific by 27.1% during the 2nd quarter. Rhumbline Advisers now owns 6,197 shares of the company’s stock worth $213,000 after acquiring an additional 1,320 shares during the period. 49.37% of the stock is owned by institutional investors.

Semler Scientific Company Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.